Fund HoldingsACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$152.89M
Total Bought
$9.08M
Total Sold
$5.96M
Net Transaction
+$3.12M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
PUMA BIOTECHNOLOGY INC3,940,0524,131,299+191,24711,66314,1709.27%+2,508
AURA BIOSCIENCES INC590,508595,744+5,2361,4533,7292.44%+2,276
TERNS PHARMACEUTICALS INC1,971,2641,971,26405,4417,3534.81%+1,912
CG ONCOLOGY INC(CGON)1,131,5011,131,501027,72229,41919.24%+1,697
ONKURE THERAPEUTICS INC1,439,6742,839,674+1,400,0005,1246,7874.44%+1,663
CYBIN INC734,394734,39404,6636,1624.03%+1,498
Y-MABS THERAPEUTICS INC3,235,3873,418,995+183,60814,33315,42010.09%+1,087
CANDEL THERAPEUTICS INC2,152,2522,580,517+428,26512,16013,0578.54%+897
BIOATLA INC4,032,0464,835,111+803,0651,4111,9151.25%+503
UROGEN PHARMA LTD(URGN)1,516,3031,259,749-256,55416,77017,25911.29%+488
WHITEHAWK THERAPEUTICS INC1,139,3631,139,36302,0282,1311.39%+103
MURAL ONCOLOGY PLC1,269,715653,779-615,9361,6001,6151.06%+15
VYNE THERAPEUTICS INC785,938736,572-49,3661,2421,2150.79%-26
CARDIF ONCOLOGY INC1,442,3081,408,767-33,5414,5294,4382.90%-91
Q32 BIO INC.803,425803,42501,3261,1970.78%-129
PROTARA THERAPEUTICS INC1,279,8001,752,115+472,3155,4525,3093.47%-143
ACRIVON THERAPEUTICS INC405,237405,23708234820.32%-340
X4 PHARMACEUTICALS INC7,310,650153,730-7,156,9201,7552920.19%-1,462
VERASTEM INC779,498779,49804,7003,2352.12%-1,465
TREVI THERAPEUTICS INC(TRVI)2,144,8442,144,844013,49111,7327.67%-1,759
BICARA THERAPEUTICS643,382643,38208,3835,9773.91%-2,406
OPTINOSE INC422,8140-422,8143,8770-3,877
Page 1 of 1